Recruiting
Multidisciplinary Approach to Fatigue
About this study
Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour
- Condition
- Breast Cancer, Germ Cell Tumor
- Tested
- Ergospirometry
- Sponsor
- Jules Bordet Institute
Who can join
- Age
- 18 to 39 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Maximum age: 39 years
- Study condition: Breast Cancer, Germ Cell Tumor
- Age between 18 and 39 years at the time of signing the informed consent
- Patient who speaks and understands French
- Signed study informed consent form obtained prior to any study related procedures
- At minimum, a moderate (\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program
- Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor
Exclusion 3
- Refusal to participate in the study
- Patient having chosen to participate in another psychosocial intervention study for the duration of the study.
- Patients with AJCC stage IV breast cancer
Where
1 site, 1 recruiting
Institut Jules Bordet
Brussels, Belgium
Contact
-
Laura Polastro, MD
+3225413279 laura.polastro@bordet.be
Potential match only. Final eligibility is determined by the study team.